A metabonomic study of inhibition of GABA uptake in the cerebral cortex

Metabolomics

Volumn 6, Issue 1, 2010, Pages 67-77

  Nasrallah, Fatima A ^a   Balcar, Vladimir J ^b   Rae, Caroline ^a,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Aminobutyric acid; 13C NMR spectroscopy; GATs; Inhibitory activity; Metabolomics

Indexed keywords

CAVIA;

EID: 77949284744     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-009-0176-0     Document Type: Article

References (52)

1. Borden, L. A., Dhar, T. G., Smith, K. E., Branchek, T. A., Gluchowski, C., & Weinshank, R. L. (1994). Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site. Receptors and Channels, 2, 207-213.
2. Borden, L. A., Smith, K. E., Gustafson, E. L., Branchek, T. A., & Weinshank, R. L. (1995). Cloning and expression of a betaine/GABA transporter from human brain. Journal of Neurochemistry, 64, 977-984.
3. Bröer, S., Bröer, A., Hansen, J. T., Bubb, W. A., Balcar, V. J., Nasrallah, F. A., et al. (2007). Alanine metabolism, transport and cycling in the brain. Journal of Neurochemistry, 102, 1758-1770.
4. Broer, S., Broer, A., Schneider, H. P., Stegen, C., Halestrap, A. P., & Deitmer, J. W. (1999). Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochemical Journal, 341, 529-535.
5. Bröer, S., & Brookes, N. (2001). Transfer of glutamine between astrocytes and neurons. Journal of Neurochemistry, 77, 705-719.
6. Cammack, J. N., & Schwartz, E. A. (1996). Channel behavior in a gamma-aminobutyrate transporter. Proceedings of the National Academy of Sciences of the United States of America, 93, 723-727.
7. Chatton, J. Y., Pellerin, L., & Magistretti, P. J. (2003). GABA uptake into astrocytes is not associated with significant metabolic cost: Implications for brain imaging of inhibitory transmission. Proceedings of the National Academy of Sciences of the United States of America, 100, 12456-12461.
8. Conti, F., Minelli, A., & Melone, M. (2004). GABA transporters in the mammalian cerebral cortex: Localization, development and pathological implications. Brain Research Reviews, 45, 196-212.
9. Coomans, D., Broeckaert, I., Derde, M. P., Tassin, A., Massart, D. L., & Wold, S. (1984). Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles. Computers and Biomedical Research, 17, 1-14.
10. Dalby, N. O. (2000). GABA level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology, 39, 2399-2407.
11. Dalby, N. O. (2003). Inhibition of γ-aminobutyric acid uptake: Anatomy, physiology and effects against epileptic seizures. European Journal of Pharmacology, 479, 127-137.
12. Dericioglu, N., Garganta, C. L., Petroff, O. A., Mendelsohn, D., & Williamson, A. (2008). Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices. Neurochemistry International, 53, 22-32.
13. Dienel, G. A., & Cruz, N. F. (2009). Exchange-mediated dilution of brain lactate specific activity: Implications for the origin of glutamate dilution and the contributions of glutamine dilution and other pathways. Journal of Neurochemistry, 109(s1), 30-37.
14. A receptors. Nature Reviews. Neuroscience, 6, 215-229.
15. Galvan, A., Villalba, R. M., West, S. M., Maidment, N. T., Ackerson, L. C., Smith, Y., et al. (2005). GABAergic modulation of the activity of globus pallidus neurons in primates: In vivo analysis of the functions of GABA receptors and GABA transporters. Journal of Neurophysiology, 94, 990-1000.
16. Giusti, P., Guidotti, A., Wojciech, D., Auta, J., & Costa, E. (1990). Neuropharmacological evidence for an interaction between the GABA uptake inhibitor Cl-966 and anxiolytic benzodiazepines. Drug Development Research, 21, 217-225.
17. 13C NMR sensitivity using a CryoProbe detects evidence of a glial metabolon. Neurochemistry International, 42, 93-99.
18. Griffin, J. L., Rae, C., Dixon, R. M., Radda, G. K., & Matthews, P. M. (1998). Excitatory amino acid synthesis in hypoxic brain slices: Does alanine act as a substrate for glutamate production in hypoxia? Journal of Neurochemistry, 71, 2477-2486.
19. Iversen, L. (2006). Neurotransmitter transporter and their impact on the development of psychopharmacology. British Journal of Pharmacology, 147, s82-s88.
20. Keros, S., & Hablitz, J. J. (2005). Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABA(A) conductances in rat neocortex. Journal of Neurophysiology, 94, 2073-2085.
21. Kinney, G. A. (2005). GAT-3 transporters regulate inhibition in the neocortex. Journal of Neurophysiology, 94, 4533-4537.
22. Krause, S., & Schwarz, W. (2005). Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1. Molecular Pharmacology, 68, 1728-1735.
23. LaRoche, S. M., & Helmers, S. L. (2004). The new antiepileptic drugs. Journal of the American Medical Association, 291, 605-614.
24. 1H NMR spectroscopy. NMR in Biomedicine, 15, 37-44.
25. Lodge, D., Curtis, D. R., & Johnston, G. A. R. (1978). Does uptake limit the action of GABA agonists in vivo? Experiments with muscimol, isoguvacine and THIP in car spinal cord. Journal of Neurochemistry, 31, 1525-1528.
26. Madsen, K. K., Clausen, R. P., Larsson, O. M., Krogsgaard-Larsen, P., Schousboe, A., & Steve White, H. (2008). Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs (pp. 139-144). Beijing: Wiley-Blackwell Publishing, Inc., 2008 Jun 27-Jul 01.
27. Matskevitch, I., Wagner, C. A., Stegen, C., Broer, S., Noll, B., Risler, T., et al. (1999). Functional characterization of the betaine/gamma-aminobutyric acid transporter BGT-1 expressed in Xenopus oocytes. Journal of Biological Chemistry, 274, 16709-16716.
28. McIlwain, H., & Bachelard, H. (1985). Biochemistry and the central nervous system. Edinburgh: Churchill Livingstone.
29. Minelli, A., DeBiasi, S., Brecha, N. C., Zuccarello, L. V., & Conti, F. (1996). GAT-3, a high affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. Journal of Neuroscience, 16, 6255-6264.
30. Mody, I. (2001). Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochemical Research, 26, 907-913.
31. Möhler, H. (2006). GABAA receptor diversity and pharmacology. Cell and Tissue Research, 326, 505-516.
32. Moussa, C. E.-H., Rae, C., Bubb, W. A., Griffin, J. L., Deters, N. A., & Balcar, V. J. (2007). Inhibitors of glutamate transport modulate distinct patterns in brain metabolism. Journal of Neuroscience Research, 85, 342-350.
33. Nasrallah, F., Griffin, J. L., Balcar, V. J., & Rae, C. (2007). Understanding your inhibitions. Modulation of brain cortical metabolism by GABA-B receptors. Journal of Cerebral Blood Flow and Metabolism, 27, 1510-1520.
34. Overstreet, L. S., & Westbrook, G. L. (2001). Paradoxical reduction of synaptic inhibition by vigabatrin. Journal of Neurophysiology, 86, 596-603.
35. - currents. Molecular Pharmacology, 39, 691-696.
36. Rae, C., Hare, N., Bubb, W. A., McEwan, S. R., Bröer, A., McQuillan, J. A., et al. (2003). Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: Further evidence for metabolic compartmentation. Journal of Neurochemistry, 85, 503-514.
37. Rae, C., Lawrance, M. L., Dias, L. S., Provis, T., Bubb, W. A., & Balcar, V. J. (2000). Strategies for studies of potentially neurotoxic mechanisms involving deficient transport of L-glutamate: Antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pigs brain slices. Brain Research Bulletin, 53, 373-381.
38. 13C NMR spectroscopy and metabolomic study. Journal of Neurochemistry, 92, 405-416.
39. Rae, C., Moussa, C. E.-H., Griffin, J. L., Parekh, S. B., Bubb, W. A., Hunt, N. H., et al. (2006). A metabolomic approach to ionotropic glutamate receptor subtype function: A nuclear magnetic resonance in vitro investigation. Journal of Cerebral Blood Flow and Metabolism, 26, 1005-1017.
40. Rae, C., Nasrallah, F. A., Griffin, J. L., & Balcar, V. J. (2009). Now I know my ABC. A systems neurochemistry and functional metabolomic approach to understanding the GABAergic system. Journal of Neurochemistry, 109(Suppl 1), 109-116.
41. Rogawski, M. A., & Löscher, W. (2004). The neurobiology of antiepileptic drugs. Nature Reviews. Neuroscience, 5, 553-564.
42. Smith, M. D., Saunders, G. W., Clausen, R. P., Frølund, B., Krogsgaard-Larsen, P., Larsson, O. M., et al. (2008). Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC). Epilepsy Research, 79, 6-13.
43. Stanton, D., Liao, L. P., Moussa, C. E.-H., Rae, C., Bubb, W. A., & Balcar, V. J. (2003). Can inhibition of glutamate transport contribute to the action of neuroleptics? Psychaitrie (Prague), 7, 6-11.
44. Swinyard, E. A., White, H. S., Wolf, H. H., & Bondinell, W. E. (1991). Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK and F 89976A and SK and F 100330A and 4 prototype antiepileptic drugs in mice and rats. Epilepsia, 32, 569-577.
45. Tagamets, M. A., & Horwitz, B. (2001). Interpreting PET and fMRI measures of functional neural activity: The effects of synaptic inhibition on cortical activation in human imaging studies. Brain Research Bulletin, 54, 267-273.
46. Tarasenko, A. S., Linetska, M. V., Storchak, L. G., & Himmelreich, N. H. (2006). Effectiveness of extracellular lactate/pyruvate for sustaining synaptic vesicle proton gradient generation and vesicular accumulation of GABA. Journal of Neurochemistry, 99, 787-796.
47. Trevelyan, A. J., Sussillo, D., & Yuste, R. (2007). Feedforward inhibition contributes to the control of epileptiform propagation speed. Journal of Neuroscience, 27, 3383-3387.
48. Wold, S. (1994). Exponentially weighted moving principal components analysis and projections to latent structures. Chemometrics and Intelligent Laboratory Systems., 23, 149-161.
49. Wu, Y., Wang, W. G., & Richerson, G. B. (2001). GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. Journal of Neuroscience, 21, 2630-2639.
50. Wu, Y., Wang, W., & Richerson, G. B. (2003). Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. Journal of Neurophysiology, 89, 2021-2034.
51. Yasumi, M., Sato, K., Shimada, S., Nishimura, M., & Tohyama, M. (1997). Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: Comparison with glutamic acid decarboxylase(67)(GAD(67))mRNA localization. Molecular Brain Research, 44, 205-218.
52. Zhu, X. M., & Ong, W. Y. (2004). A light and electron microscopic study of betaine/GABA transporter distribution in the monkey cerebral neocortex and hippocampus. Journal of Neurocytology, 33, 233-240.